DK0525199T4 - Sammensætning indeholdende ultrafine partikler af magnetisk metaloxid - Google Patents
Sammensætning indeholdende ultrafine partikler af magnetisk metaloxidInfo
- Publication number
- DK0525199T4 DK0525199T4 DK92903328T DK92903328T DK0525199T4 DK 0525199 T4 DK0525199 T4 DK 0525199T4 DK 92903328 T DK92903328 T DK 92903328T DK 92903328 T DK92903328 T DK 92903328T DK 0525199 T4 DK0525199 T4 DK 0525199T4
- Authority
- DK
- Denmark
- Prior art keywords
- metal oxide
- composition containing
- magnetic metal
- containing ultrafine
- oxide particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
- G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
- G01N2400/22—Dextran
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/20—Magnetic particle immunoreagent carriers the magnetic material being present in the particle core
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/30—Magnetic particle immunoreagent carriers the magnetic material being dispersed in the polymer composition before their conversion into particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/806—Electrical property or magnetic property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Soft Magnetic Materials (AREA)
- Compounds Of Iron (AREA)
- Hard Magnetic Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1951291 | 1991-01-19 | ||
PCT/JP1992/000031 WO1992012735A1 (en) | 1991-01-19 | 1992-01-17 | Composition containing ultrafine particles of magnetic metal oxide |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0525199T3 DK0525199T3 (da) | 1999-11-01 |
DK0525199T4 true DK0525199T4 (da) | 2004-06-01 |
Family
ID=12001420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92903328T DK0525199T4 (da) | 1991-01-19 | 1992-01-17 | Sammensætning indeholdende ultrafine partikler af magnetisk metaloxid |
Country Status (13)
Country | Link |
---|---|
US (1) | US5328681A (da) |
EP (1) | EP0525199B2 (da) |
JP (1) | JP2921984B2 (da) |
AT (1) | ATE179894T1 (da) |
AU (1) | AU652804B2 (da) |
CA (1) | CA2078679C (da) |
DE (2) | DE10199065I2 (da) |
DK (1) | DK0525199T4 (da) |
ES (1) | ES2131067T5 (da) |
LU (1) | LU91003I2 (da) |
NL (1) | NL300088I1 (da) |
NO (2) | NO305636B1 (da) |
WO (1) | WO1992012735A1 (da) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0689430B1 (de) * | 1993-03-17 | 1997-08-13 | Silica Gel Ges.M.B.H | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
CA2182213A1 (en) * | 1994-01-28 | 1995-08-03 | William George Gorman | Oral magnetic particle formulation |
DE4428851C2 (de) * | 1994-08-04 | 2000-05-04 | Diagnostikforschung Inst | Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie |
DE19509694A1 (de) * | 1995-03-08 | 1996-09-19 | Schering Ag | Verwendung von Magnetiten zur Bestimmung der Perfusion von menschlichem Gewebe mittels MR-Diagnostik |
GB9600427D0 (en) * | 1996-01-10 | 1996-03-13 | Nycomed Imaging As | Contrast media |
CN1212629A (zh) | 1996-01-10 | 1999-03-31 | 耐克麦德英梅金公司 | 造影剂 |
US5855868A (en) * | 1996-04-01 | 1999-01-05 | Nycomed Imaging As | Method of T1 -weighted resonance imaging of RES organs |
FR2749082B1 (fr) * | 1996-05-24 | 1998-06-26 | Bio Merieux | Particules superparamagnetiques et monodispersees |
AU727764B2 (en) * | 1996-08-05 | 2000-12-21 | Schering Aktiengesellschaft | Process for the production of contrast media for magnetic resonance tomography |
GB2319253A (en) | 1996-11-16 | 1998-05-20 | Eric Leigh Mayes | Composition, for use in a device, comprising a magnetic layer of domain-separated magnetic particles |
US6713173B2 (en) | 1996-11-16 | 2004-03-30 | Nanomagnetics Limited | Magnetizable device |
US20060003163A1 (en) * | 1996-11-16 | 2006-01-05 | Nanomagnetics Limited | Magnetic fluid |
US6986942B1 (en) | 1996-11-16 | 2006-01-17 | Nanomagnetics Limited | Microwave absorbing structure |
US6815063B1 (en) | 1996-11-16 | 2004-11-09 | Nanomagnetics, Ltd. | Magnetic fluid |
US6725078B2 (en) * | 2000-01-31 | 2004-04-20 | St. Louis University | System combining proton beam irradiation and magnetic resonance imaging |
JP4448642B2 (ja) | 2000-03-06 | 2010-04-14 | シーメンス・ヘルスケア・ダイアグノスティックス・プロダクツ・ゲーエムベーハー | 多糖で被覆された担体、その製造および使用 |
US6743395B2 (en) * | 2000-03-22 | 2004-06-01 | Ebara Corporation | Composite metallic ultrafine particles and process for producing the same |
US7169618B2 (en) * | 2000-06-28 | 2007-01-30 | Skold Technology | Magnetic particles and methods of producing coated magnetic particles |
DE10154016B4 (de) * | 2001-10-26 | 2004-02-12 | Berlin Heart Ag | Magnetflüssigkeit und Verfahren zur ihrer Herstellung |
US20030185757A1 (en) * | 2002-03-27 | 2003-10-02 | Mayk Kresse | Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
WO2004016316A1 (ja) * | 2002-08-16 | 2004-02-26 | Admetec Co., Ltd. | 加熱方法及びそのための加熱装置 |
CN1744906B (zh) * | 2003-01-31 | 2010-08-18 | 株式会社大塚制药工厂 | 利用介电加热的癌症治疗方法中所使用的辅助剂以及癌症治疗方法 |
FR2861994A1 (fr) * | 2003-11-12 | 2005-05-13 | Guerbet Sa | Nouvel agent de diagnostic pour l'irm dans les pathologies impliquant des proteinases |
US7907987B2 (en) | 2004-02-20 | 2011-03-15 | University Of Florida Research Foundation, Inc. | System for delivering conformal radiation therapy while simultaneously imaging soft tissue |
JP3822229B2 (ja) * | 2004-05-27 | 2006-09-13 | 松下電器産業株式会社 | 基板上への微粒子配列体の形成方法 |
EP1810688A1 (en) * | 2004-11-10 | 2007-07-25 | Konica Minolta Medical & Graphic, Inc. | Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
JP5354566B2 (ja) * | 2008-07-25 | 2013-11-27 | 名糖産業株式会社 | カチオン性多糖磁性粒子複合体 |
US20110288505A1 (en) * | 2008-09-29 | 2011-11-24 | Vifor (International) Ag | Receptacle And Method For Storing And Supplying A Liquid And A Liquid Medical Preparation |
IT1398263B1 (it) | 2010-03-04 | 2013-02-22 | Monzani | Nanoparticelle magnetiche di ossido di ferro a dimensione controllata per la diagnosi ed il trattamento di neoplasie avanzate e metastatiche |
DE102011112898A1 (de) | 2011-09-08 | 2013-03-14 | Charité - Universitätsmedizin Berlin | Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen |
US10561861B2 (en) | 2012-05-02 | 2020-02-18 | Viewray Technologies, Inc. | Videographic display of real-time medical treatment |
JP6535857B2 (ja) * | 2015-03-16 | 2019-07-03 | 国立大学法人 岡山大学 | γ−酸化鉄の製造方法 |
AU2017227590A1 (en) | 2016-03-02 | 2018-08-30 | Viewray Technologies, Inc. | Particle therapy with magnetic resonance imaging |
KR20190092530A (ko) | 2016-12-13 | 2019-08-07 | 뷰레이 테크놀로지스 인크. | 방사선 치료 시스템 및 방법 |
US11033758B2 (en) | 2017-12-06 | 2021-06-15 | Viewray Technologies, Inc. | Radiotherapy systems, methods and software |
US11209509B2 (en) | 2018-05-16 | 2021-12-28 | Viewray Technologies, Inc. | Resistive electromagnet systems and methods |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001288A (en) * | 1965-09-15 | 1977-01-04 | Howard S. Gable | Magnetic organo-iron compounds |
US4452773A (en) * | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
SE463651B (sv) * | 1983-12-21 | 1991-01-07 | Nycomed As | Diagnostikum och kontrastmedel |
AU4634685A (en) * | 1984-06-22 | 1986-01-24 | R.L. Veech | Electrolyte solutions and in vivo use thereof |
US4795698A (en) * | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
JPH0616444B2 (ja) * | 1986-03-05 | 1994-03-02 | 鹿島石油株式会社 | 磁性ミクロスフエアの製造方法 |
US5102652A (en) * | 1986-07-03 | 1992-04-07 | Advanced Magnetics Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
US5160726A (en) * | 1990-02-15 | 1992-11-03 | Advanced Magnetics Inc. | Filter sterilization for production of colloidal, superparamagnetic MR contrast agents |
US4827945A (en) * | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
SE8704157L (sv) * | 1987-10-26 | 1989-04-27 | Carbomatrix Ab C O Ulf Schroed | Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning |
US5114703A (en) * | 1989-05-30 | 1992-05-19 | Alliance Pharmaceutical Corp. | Percutaneous lymphography using particulate fluorocarbon emulsions |
JP2726520B2 (ja) * | 1989-10-20 | 1998-03-11 | 名糖産業株式会社 | 有機磁性複合体 |
-
1992
- 1992-01-17 WO PCT/JP1992/000031 patent/WO1992012735A1/ja active IP Right Grant
- 1992-01-17 US US07/934,637 patent/US5328681A/en not_active Expired - Lifetime
- 1992-01-17 DE DE2001199065 patent/DE10199065I2/de active Active
- 1992-01-17 DE DE69229150T patent/DE69229150T3/de not_active Expired - Lifetime
- 1992-01-17 AU AU11689/92A patent/AU652804B2/en not_active Expired
- 1992-01-17 JP JP4503597A patent/JP2921984B2/ja not_active Expired - Lifetime
- 1992-01-17 DK DK92903328T patent/DK0525199T4/da active
- 1992-01-17 EP EP92903328A patent/EP0525199B2/en not_active Expired - Lifetime
- 1992-01-17 CA CA002078679A patent/CA2078679C/en not_active Expired - Lifetime
- 1992-01-17 AT AT92903328T patent/ATE179894T1/de active
- 1992-01-17 ES ES92903328T patent/ES2131067T5/es not_active Expired - Lifetime
- 1992-09-15 NO NO923584A patent/NO305636B1/no not_active IP Right Cessation
-
2002
- 2002-04-11 NL NL300088C patent/NL300088I1/nl unknown
- 2002-05-16 NO NO2002003C patent/NO2002003I2/no unknown
-
2003
- 2003-01-24 LU LU91003C patent/LU91003I2/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2078679C (en) | 2006-12-05 |
NO923584D0 (no) | 1992-09-15 |
AU652804B2 (en) | 1994-09-08 |
ES2131067T5 (es) | 2004-10-16 |
DE69229150D1 (de) | 1999-06-17 |
NO2002003I2 (no) | 2005-04-04 |
WO1992012735A1 (en) | 1992-08-06 |
EP0525199A1 (en) | 1993-02-03 |
ATE179894T1 (de) | 1999-05-15 |
DK0525199T3 (da) | 1999-11-01 |
JP2921984B2 (ja) | 1999-07-19 |
NO305636B1 (no) | 1999-07-05 |
EP0525199A4 (en) | 1994-08-17 |
LU91003I2 (en) | 2003-03-24 |
NO923584L (no) | 1992-11-12 |
EP0525199B1 (en) | 1999-05-12 |
DE69229150T3 (de) | 2005-01-05 |
AU1168992A (en) | 1992-08-27 |
CA2078679A1 (en) | 1992-07-20 |
DE10199065I2 (de) | 2004-09-23 |
EP0525199B2 (en) | 2004-04-14 |
NL300088I1 (nl) | 2002-07-01 |
DE69229150T2 (de) | 1999-09-30 |
ES2131067T3 (es) | 1999-07-16 |
DE10199065I1 (de) | 2002-02-21 |
US5328681A (en) | 1994-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0525199T4 (da) | Sammensætning indeholdende ultrafine partikler af magnetisk metaloxid | |
DE69223748T2 (de) | Oxidierte zusammensetzung, enthaltend ein wasserlösliches carboxypolysaccharid und magnetisches eisenoxid | |
DE68927189T2 (de) | Arzneimittel, die Lanthionin enthaltenden Bacteriozin enthalten, zur Verwendung als Bakterizide | |
DE3650644D1 (de) | Magnetische Polymerpartikeln | |
IT8323311A0 (it) | Particolarmente per l'infusione di dispositivo e procedimento per medicine od altri liquidi medicali l'infusione di medicazioni, in un organismo vivente. | |
FI865336A0 (fi) | Foerfarande foer framstaellning av en snabbt framstaellbar homogen mikrokapselsuspension. | |
FI940144A (fi) | Vasta-aineiden tuotanto | |
BE904831A (fr) | Composition d'activateur tissulaire du plasminogene. | |
PT83825A (de) | Mittel zur bestimmung von peroxidase-aktivitaet mit stabilisator verfahren zur herstellung und seine verwendung | |
KR890001525A (ko) | 지효성 경피 제제 | |
DE3880532D1 (de) | Waesserige zusammensetzungen, welche eine kationische verbindung und xanthangummi enthalten. | |
DE69001734T2 (de) | Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung. | |
DE69304409T2 (de) | Neues Hexapeptid | |
EP0373388A3 (de) | Penemderivate und Verfahren zu ihrer Herstellung | |
FI942941A0 (fi) | Humaaniproteiini C:n käyttö trombosyyttien saostumisen estämiseen ja hoitoon | |
UA9626A (uk) | Спосіб діагностики вперше виявленого туберкульозу легень | |
FI913661A (fi) | Ferromagneettisten tuotteiden koodaus- ja tunnistusmenetelmä | |
RO82357B1 (ro) | Medicament dezinfectant si cicatrizant |